ECONOMICS.
EXPERTS.
EXPERIENCE.
Momentous challenges require certainty. That's why we provide the clarity and confidence you need—with defensible solutions and results grounded in the most rigorous analysis—to make your most important decisions.
Our experts analyze US market trends following Humira’s loss of exclusivity, highlighting steep price declines, biosimilar uptake, and implications for manufacturers, payers, and healthcare providers.